Feener Edward P. 4
4 · KalVista Pharmaceuticals, Inc. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Feener Edward P.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-11$13.03/sh−22,679$295,514→ 39,828 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated July 20, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.